Second neoplasms in chronic lymphocytic leukemia: Are case-group studies useful?

Leukemia and Lymphoma

Volumn 47, Issue 11, 2006, Pages 2265-2266

  Molica, Stefano ^a  

^a PUGLIESE CIACCIO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; FLUDARABINE;

CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; DISEASE ASSOCIATION; EVIDENCE BASED PRACTICE; FOLLOW UP; HUMAN; IMMUNE DEFICIENCY; KAPOSI SARCOMA; LARYNX CARCINOMA; LIFESTYLE; MAINTENANCE THERAPY; MELANOMA; MYELODYSPLASTIC SYNDROME; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; SECOND CANCER; SMOKING CESSATION;

ANTINEOPLASTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; NEOPLASMS, SECOND PRIMARY;

EID: 33751108968     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190600901500     Document Type: Note

References (6)

1. Wiernik, P. (2004) Second neoplasm in patients with chronic lymphocytic leukemia Curr Treat Options Oncol, 5, pp. 215-223.
2. Travis, L.(2006) Cancer Survivorship: Undestanding risk. ASCO Educational Book.
3. Molica, S. (2005) Second neoplasms in chronic lymphocytic leukemia: incidence and pathogenesis with emphasis on the role of different therapies Leuk Lymphoma, 46, pp. 49-54.
4. Hisada, M and Biggar, R and Greene, M and Fraumeni, J, Jr and Travis, L. (2001) Solid tumors after chronic lymphocytic leukemia Blood, 98, pp. 1979-1981.
5. Callea, V and Brugiatelli, M and Stelitano, C and Gentile, M and Nobile, F and Morabito, F. (2006) Incidence of second neoplasia in patients with B-cell chronic lymphocytic leukemia treated with chlorambucil maintenance chemotherapy Leuk Lymphoma, 47(11), pp. 2314-2320.
6. Morrison, V and Rai, K and Peterson, B and Kaliz, J and Elias, L and Appelbaum, F and (2002) Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: Results of an Intergroup Study, Cancer and Leukemia Group B 9011 J Clin Oncol, 20, pp. 3878-3884.